Insider Enric Alventosa Abril plans CRGO share sale (NASDAQ: CRGO)

Rhea-AI Filing Summary

CRGO insider plans additional stock sales under Rule 144. The notice states that Enric Alventosa Abril intends to sell 2,286 ordinary shares through Oppenheimer & Co. on or about 01/16/2026 on Nasdaq, with an aggregate market value of 6,172.20. The shares to be sold come from restricted stock units granted by the issuer on 09/06/2023 for 25,683 securities and on 07/29/2024 for 17,739 securities. The filing also lists recent sales over the prior three months, including 2,177 ordinary shares sold on 10/16/2025 and 3,063 shares sold on 11/26/2025 for gross proceeds of 9,865.80.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co. Inc. 85 Broad St New York NY 10004	2286	6172.20	49726906	01/16/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	09/06/2023	Restricted stock units	Issuer			25683	09/06/2023	N/A
Ordinary	07/29/2024	Restricted stock units	Issuer			17739	07/29/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Enric Alventosa Abril PLANTA 10, AVDA. DIAGONAL BARCELONA U3 08018	Ordinary	10/16/2025	2177	7902.51
Enric Alventosa Abril PLANTA 10, AVDA. DIAGONAL BARCELONA U3 08018	Ordinary	11/19/2025	3859	11196.77
Enric Alventosa Abril PLANTA 10, AVDA. DIAGONAL BARCELONA U3 08018	Ordinary	11/20/2025	3000	8940.00
Enric Alventosa Abril PLANTA 10, AVDA. DIAGONAL BARCELONA U3 08018	Ordinary	11/24/2025	3000	9300.00
Enric Alventosa Abril PLANTA 10, AVDA. DIAGONAL BARCELONA U3 08018	Ordinary	11/26/2025	3063	9865.80

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the CRGO Form 144 filing disclose?

The Form 144 notice discloses that Enric Alventosa Abril plans to sell 2,286 ordinary shares of CRGO on Nasdaq through Oppenheimer & Co. Inc., with an aggregate market value of 6,172.20, under Rule 144.

How many CRGO shares are planned for sale in this Form 144?

The filing indicates a planned sale of 2,286 ordinary shares of CRGO, to be executed on or about 01/16/2026 via Oppenheimer & Co. Inc. on Nasdaq.

What is the source of the CRGO shares being sold by Enric Alventosa Abril?

The shares come from restricted stock units granted by the issuer, including 25,683 securities acquired on 09/06/2023 and 17,739 securities acquired on 07/29/2024, both listed as ordinary shares.

Which broker is handling the planned CRGO share sale?

The planned sale of 2,286 ordinary CRGO shares is to be handled by Oppenheimer & Co. Inc., located at 85 Broad St, New York, NY 10004, with trading on Nasdaq.

What recent CRGO share sales by Enric Alventosa Abril are disclosed?

The notice lists several sales of CRGO ordinary shares in the prior three months, including 2,177 shares sold on 10/16/2025 and 3,063 shares sold on 11/26/2025 for gross proceeds of 9,865.80.

What representation does the seller make in the CRGO Form 144?

By signing the notice, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, and acknowledges that intentional misstatements or omissions constitute federal criminal violations.